US2010047911A1PendingUtilityA1

Compositions and methods for isolation, propagation, and differentiation of human stem cells and uses thereof

Assignee: LEVESQUE BIOSCIENCES INCPriority: Aug 8, 2001Filed: Oct 30, 2009Published: Feb 25, 2010
Est. expiryAug 8, 2021(expired)· nominal 20-yr term from priority
C12N 2501/119C12N 2501/115C12N 2501/13C12N 2501/385C12N 2501/40C12N 5/0619C12N 2501/01C12N 2501/23A61K 35/12
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention is directed to the field of human stem cells and includes methods and compositions for isolating, propagating, and differentiating human stem cells. The invention provides therapeutic uses of the methods and compositions, including autologous transplantation of treated cells into humans for treatment of Parkinson's and other neuronal disorders.

Claims

exact text as granted — not AI-modified
1 - 30 . (canceled) 
   
   
       31 . A cell culture medium for differentiating central nervous system (CNS) stem cells comprising RA, dBcAMP, FGF8, and GDNF. 
   
   
       32 . The cell culture medium of claim  30  comprising 10 −6  M RA, 1 mM dBcAMP, 20 ng/mi FGF8 and 20 ng/ml GDNF. 
   
   
       33 . A method of causing central nervous system stem cells to differentiate in vitro comprising culturing CNS stem cells in the cell culture medium of claim  30 . 
   
   
       34 . The cell culture medium of  claim 31  comprising about 10 −8  to about 10 −4  M RA, about 0.01 to about 3 mM dBcAMP, about 0.02 to about 200 ng/ml FGF8, and about 0.02 to about 200 ng/ml GDNF.

Join the waitlist — get patent alerts

Track US2010047911A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.